Light AI Strengthens Intellectual Property Portfolio with Two New European Patents
Light AI's European patent has been validated in the UK and Spain with utility patents covering 17 European countries
To date, Light AI's technology has been issued five US and global patents pertaining to the image processing of Streptococcal infection in Pharyngitis
VANCOUVER, BC, May 7, 2025 /CNW/ - Light AI Inc. (" Light AI" or the " Company") (CBOE CA: ALGO) (FSE: 0HC) (OTCQB: OHCFF), a healthcare technology company focused on developing artificial intelligence ("AI") health diagnostic and wellness solutions, today announced that it has expanded its patent portfolio with the addition of two new European based patents pertaining to the Company's proprietary technology; one European patent validated in the UK and Spain with another utility patent covering 17 European countries.
Light AI's proprietary technology platform is an app-based solution and is core to the advancement of patient management, as it requires no swabs, lab tests, or propriety hardware of any kind. The platform's cloud-based architecture enables access from smart devices such as smartphones and tablets commonly available in medical practices.
The platform, which is part of a suite of health and diagnostic wellness offerings, is designed to apply assistive AI algorithms to smartphone images, starting with oropharynx images to identify Strep A in seconds. The long-term vision is for the platform to identify a wide range of throat, eye skin and other medical conditions through the Company's AI oriented platform.
"Securing these patents marks a pivotal step in our global expansion strategy and helps pave the way for our commercialization launch in Europe," says Peter Whitehead, Chief Executive Officer of Light AI. "As demand for advanced medical technologies and newer solutions continues to rise across European - and global healthcare systems - these patents not only strengthen our IP portfolio, but also position us to deliver innovative solutions at scale in one of the world's most regulated and high-potential markets in future. We are building an IP moat to fortify Light AI's first mover advantage in this space."
Light AI's technology has been issued three US patents, three European patent and one Australian patent to date pertaining to the image processing of Streptococcal infection in Pharyngitis Subjects as follows:
United States
Patent number: 11,369,318
Patent number: 11,602,312
Patent number: 12,148,150
Australia
Patent number: 2019357949
European Union
Patent number: 3864669
About Light AI Inc. (CBOE CA: ALGO / FSE: 0HC / OTCQB: OHCFF)
Light AI Inc. is a technology company focused on developing artificial intelligence health diagnostic solutions. Light AI is developing a technology platform which represents the next generation of patient management: it applies AI algorithms to smartphone images—starting with images of Strep A and anticipated expansion with COVID19 along with other medical conditions —to identify the disease in seconds. Its patented, app-based solution requires no swabs, lab tests or proprietary hardware of any kind—its hardware platform is the 4.5 billion smartphones that exist in the world today. Light AI is at the forefront of developing innovative diagnostic solutions aimed at improving healthcare delivery worldwide. Their cutting-edge AI powered technology offers rapid, accurate, and cost-effective diagnostic tools designed to address critical healthcare challenges.
In pre-FDA validation studies, Light AI's algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A Streptococcus (GAS). The algorithm achieved a 96.57% accuracy rate and attained a Negative Predictive Value of 100%, indicating its high reliability in confirming the absence of Streptococcus A infection. Viral and GAS pharyngitis affects over 600 million people annually worldwide. If left untreated, GAS pharyngitis can lead to serious complications such as Rheumatic Heart Disease (RHD), which imposes a global economic burden exceeding $1 trillion annually. Light AI's technology offers a significant advancement in the accurate and timely diagnosis of GAS pharyngitis, potentially reducing the incidence of RHD and its associated costs. Light AI's approach to applying AI to smartphone images can be expanded to other throat conditions, as well as other areas of analysis, such as the human eye and skin. Light AI's vision is to combine the smartphone with AI in-the-Cloud to create a Digital Clinical Lab that provides quick and accessible diagnosis for countless conditions that today require expensive and time-consuming imaging or lab processes. Light AI's commercial launch of its consumer-facing Wellness App initial offering is anticipated to be available in North America in Q3 2025.
ON BEHALF OF THE COMPANY
For more information, please contact the Company at [email protected] or visit https://light.ai/.
Forward-Looking Information:
This news release includes information, statements, beliefs and opinions which are forward-looking, and which reflect current estimates, expectations and projections about future events, including, but not limited to, the Company's research and development and commercialization initiatives, the anticipated inflection of the business, the Company's patent and intellectual property portfolio and other statements that contain words such as "believe," "expect," "project," "should," "seek," "anticipate," "will," "intend," "positioned," "risk," "plan," "may," "estimate" or, in each case, their negative and words of similar meaning. By its nature, forward-looking information involves a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking information. These risks, uncertainties and assumptions could adversely affect the outcome of the plans and events described herein. Readers should not place undue reliance on forward-looking information, which is based on the information available as of the date of this news release. For a list of the factors that may affect any of the Company's forward-looking statements, please refer to the Company's annual information form dated April 14, 2025 and other filings made by the Company with the Canadian securities regulatory authorities (which may be viewed under its SEDAR+ profile at www.sedarplus.ca
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
6 hours ago
- Cision Canada
Statement from Dennis Darby, President & CEO, Canadian Manufacturers & Exporters regarding passage of C-5, the One Canadian Economy Act, in the House of Commons
OTTAWA, ON, June 20, 2025 /CNW/ - Canadian Manufacturers & Exporters (CME) welcomes today's passage of Bill C-5, the One Canadian Economy Act, through the House of Commons. This legislation marks a meaningful first step toward fixing Canada's fragmented and inefficient approach to infrastructure approvals - one that has held back investment, delayed major projects, and weakened our economic competitiveness. From highways and ports to pipelines and clean energy infrastructure, Canada needs to get major projects moving - faster. Bill C-5 can help pave the way for clearer oversight, reduced duplication and greater government accountability, all of which are vital building the infrastructure our economy depends on. But this is only the beginning. The passage of Bill C-5 must not be the end of the conversation - it must be the starting point for a broader transformation. The federal government must now turn its attention to a much harder task: tackling the underlying web of outdated legislation, regulatory inefficiencies, and policy contradictions that have made a bill like this necessary in the first place. Until those deeper barriers are addressed, Canada will continue to struggle to attract private sector investment in the kinds of projects - big and small, urban and rural - that create jobs, grow communities, and position our economy for long-term success. Manufacturers are looking for outcomes, not just intentions. We look forward to the Bill passing in the Senate so that we can build on this momentum and do the hard work needed to truly unlock Canada's potential. About Canadian Manufacturers & Exporters (CME) From the first industrial boom in Canada, CME has advocated for and represented member interests. 150 years strong, CME has earned an extensive and effective track record of working for thousands of leading companies nationwide. More than 85 per cent of CME's members are SMEs and collectively account for an estimated 82 per cent of total manufacturing production and 90 per cent of Canada's exports.
Cision Canada
6 hours ago
- Cision Canada
House of Commons passes One Canadian Economy Act Français
OTTAWA, ON, June 20, 2025 /CNW/ - Canada's new government has a mandate to build big, build bold, and build now. Today, the Prime Minister, Mark Carney, welcomed the passing in the House of Commons of Bill C-5, One Canadian Economy Act. The legislation will build one strong Canadian economy by: Removing federal barriers to internal trade and labour mobility, helping goods, services, workers, and businesses move freely across provinces and territories. Expediting nation-building projects that will connect and transform our country and unleash economic growth while ensuring environmental protections and Indigenous rights are upheld. Working with Indigenous Peoples through consultation and engagement to build shared prosperity. Taken together, these measures will create and connect Canadians to good-paying careers and more prosperity. The Prime Minister shared an update on this work with the premiers of the provinces and territories during their meeting earlier today. The leaders agreed to stay in close contact as they reinforce Canada's strength at home. Indigenous partnership is a critical component of this legislation, and fulsome consultation will be pivotal to the success of future projects. The Government of Canada is committed to respecting the rights of Indigenous Peoples recognized and affirmed by section 35 of the Constitution Act, 1982 and the rights set out in the United Nations Declaration on the Rights of Indigenous Peoples. To this end, Prime Minister Carney will be meeting with First Nations, Inuit, and Métis over the coming weeks. Bill C-5 now moves to the Senate for consideration and brings us one step closer to removing federal barriers to free trade by Canada Day. Quotes "Today's passing of Bill C-5, One Canadian Economy Act, will remove trade barriers, expedite nation-building projects, and unleash economic growth, with Indigenous partnership at the centre of this growth. It's time to build big, build bold, and build now. As Canadians, we can give ourselves more than any foreign nation can ever take away." — The Rt. Hon. Mark Carney, Prime Minister of Canada "The adoption of Bill C-5 by the House of Commons is a crucial step in building one Canadian economy and getting big projects built faster. Thank you to colleagues who supported this legislation – you are helping build a stronger Canada." — The Hon. Dominic LeBlanc, President of the King's Privy Council for Canada and Minister responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy "This legislation is about building a stronger, more united Canada. Let's build trust, tear down internal trade barriers, and create one single economy – from coast to coast to coast. Together, we're building a stronger Canada, for everyone." — The Hon. Chrystia Freeland, Minister of Transport and Internal Trade "I am pleased to see the One Canadian Economy Act achieve this milestone. This Act means we are no longer asking 'Why build?', but instead 'How do we get it done?'. We are removing barriers, leveraging Canada's resources and talented workers, centring Indigenous consultation and equity, and continuing to fight climate change – all to get building and to become an energy superpower. In the new economy we are building, Canada will be defined by delivery, not delay." — The Hon. Tim Hodgson, Minister of Energy and Natural Resources "Indigenous Peoples' voices are at the table where discussions are happening, and decisions are made. This government understands that Indigenous Peoples have the right to determine their future. As the first Indigenous Minister of Indigenous Services, I understand the importance of relationship moving forward – and I am pleased to see the Prime Minister has determined this as a priority and a critical part of the work ahead." — The Hon. Mandy Gull-Masty, Minister of Indigenous Services
Cision Canada
7 hours ago
- Cision Canada
Parkland Corporation Announces Execution of Supplemental Indentures for Senior Notes in Connection with the Consent Solicitations
CALGARY, AB, June 20, 2025 /CNW/ - Parkland Corporation (TSX: PKI) ("Parkland") today announced that in connection with the successful completion of its previously announced consent solicitations, Parkland, the applicable Guarantors and the applicable trustees have executed supplemental indentures (the "Supplemental Indentures") to amend the indentures (the "Indentures") governing the notes listed below (the "Notes"). The consent solicitations were made in connection with Parkland's definitive agreement whereby Sunoco LP ("Sunoco") will acquire the issued and outstanding common shares of Parkland (the "Transaction"), which was previously announced on May 5, 2025. The Supplemental Indentures amended the Indentures by (collectively, the "COC Amendments"): (a) eliminating Parkland's potential obligation under such Indenture to make a "Change of Control Offer" (as defined in such Indenture) as a result of the Transaction; and (b) amending the defined term "Change of Control" in such Indenture to provide that Sunoco and its affiliates will be "Qualified Owners" of Parkland. The Supplemental Indentures became effective upon their execution and are binding on all Holders, as defined in that certain consent solicitation statement issued on May 27, 2025 (the "Consent Solicitation Statement"), including those who did not deliver a consent at or prior to the Expiration Date, as defined in the Consent Solicitation Statement. The COC Amendments will cease to become operative if the Transaction is not consummated or if the applicable consent fees are not paid to the applicable depositary or tabulation agent. This press release is for informational purposes only and does not amend the consent solicitations, which have expired and were made solely on the terms and subject to the conditions set forth in the consent solicitation statement. Further, this press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes or any other securities. Please refer to the earlier press releases dated May 27, 2025 and June 10, 2025, in connection with the consent solicitations for more information. Forward-Looking Statements Certain statements contained herein constitute forward-looking information and statements (collectively, "forward-looking statements"). When used in this news release, the words "believes", "expects", "expected", "will", "plan", "intends", "target", "would", "seek", "could", "projects", "projected", "anticipates", "estimates", "continues" and similar expressions are intended to identify forward-looking statements. In particular, this news release contains forward-looking statements with respect to, among other things, the Transaction. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements should not be unduly relied upon. These forward-looking statements speak only as of the date hereof. Parkland does not undertake any obligations to publicly update or revise any forward-looking statements except as required by securities laws. Without limiting the generality of the foregoing, forward-looking statements contained in this press release specifically include statements regarding the consummation of the Transaction. Actual results could differ materially from those anticipated in these forward-looking statements as a result of numerous risks, assumptions and uncertainties. For more information, please see the risks and uncertainties described under the headings "Cautionary Statement Regarding Forward-Looking Information" and "Risk Factors" in Parkland's current Annual Information Form dated March 5, 2025, and under the headings "Forward-Looking Information" and "Risk Factors" included in the Q1 2025 Management's Discussion and Analysis dated May 5, 2025, each as filed on SEDAR+ and available on Parkland's website at The forward-looking statements contained herein are expressly qualified by this cautionary statement. About Parkland Corporation Parkland is a leading international fuel distributor, marketer, and convenience retailer with safe and reliable operations in 26 countries across the Americas. Our retail network meets the fuel and convenience needs of everyday consumers. Our commercial operations provide businesses with fuel to operate, complete projects and better serve their customers. In addition to meeting our customers' needs for essential fuels, Parkland provides a range of choices to help them lower their environmental impact, including manufacturing and blending renewable fuels, ultra-fast EV charging, a variety of solutions for carbon credits and renewables, and solar power. With approximately 4,000 retail and commercial locations across Canada, the United States and the Caribbean region, we have developed supply, distribution and trading capabilities to accelerate growth and business performance.
